Zurich Cantonal Bank
BIOA

Zurich Cantonal Bank’s BioAmber Inc. BIOA Stock Holding History

Zurich Cantonal Bank’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-15,000
Closed -$150K – 996
2014
Q3 		$150K Buy
+15,000
New +$176K ﹤0.01% 799

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Zurich Cantonal Bank's BIOA Position: Q4 2014 in Review

Zurich Cantonal Bank sold out of BioAmber Inc. (BIOA) in Q4 2014, closing a stake of 15,000 shares — an estimated $150K sold.

Zurich Cantonal Bank first reported a position in BIOA in Q3 2014 and held it in 1 quarter. The position peaked at $150K in Q3 2014. 33 funds tracked by Wall St. Rank hold BIOA as of Q4 2014.

  • Zurich Cantonal Bank reported no remaining BioAmber Inc. position as of Q4 2014 after selling out during the quarter.
  • Zurich Cantonal Bank sold 15,000 BioAmber Inc. shares in Q4 2014, an estimated $150K.
  • Zurich Cantonal Bank first reported a position in BioAmber Inc. in Q3 2014 and held it in 1 quarter.
  • Zurich Cantonal Bank's BioAmber Inc. position peaked at $150K in Q3 2014.
  • 33 funds tracked by Wall St. Rank held BioAmber Inc. as of Q4 2014.

Based on Zurich Cantonal Bank's 13F filing for Q4 2014, filed 29 Jan 2015.